Substance abuse increases the risk of neuropathy in an HIV‐infected cohort
- 18 November 2011
- journal article
- research article
- Published by Wiley in Muscle & Nerve
- Vol. 45 (4), 471-476
- https://doi.org/10.1002/mus.23231
Abstract
Introduction: Human immunodeficiency virus (HIV)‐infected patients commonly develop distal symmetric polyneuropathy (DSP). Age, ethnicity, and toxic exposures may influence the risk. In this study we examined the association between substance use, antiretrovirals, ethnicity, and incident neuropathy in an HIV‐infected cohort. Methods: Data were obtained from the National NeuroAIDS Tissue Consortium (NNTC), an ongoing, prospective cohort started in 1998. Cox proportional hazards models were used to examine the association of substance use, demographics, neurotoxic antiretrovirals, and laboratory parameters with incident neuropathy in 636 participants who were neuropathy‐free at baseline. Results: The cumulative incidence of DSP was 41%. Substance use (P = 0.04), number of substances used (P = 0.04), and longer duration of HIV infection (P = 0.05) were associated with incident DSP, but demographic factors, use of neurotoxic antiretrovirals, and laboratory parameters were not. Conclusions: Substance use and longer duration of HIV infection are risk factors for DSP in HIV‐infected patients. Use of multiple substances may be particularly risky. Muscle Nerve, 2012Keywords
Funding Information
- NIH (K23 NS066789, U01MH083501, R24MH59724)
- Manhattan HIV Brain Bank (U01MH083507, R24 NS45491)
- Texas NeuroAIDS Research Center (5U01MH083500, NS 38841)
- National Neurological AIDS Bank (U01MH083506, R24MH59745)
- California NeuroAIDS Tissue Network (U01MH083545, N01MH32002)
- Statistics and Data Coordinating Center
This publication has 20 references indexed in Scilit:
- Cocaine-mediated enhancement of Tat toxicity in rat hippocampal cell cultures: The role of oxidative stress and D1 dopamine receptorNeuroToxicology, 2006
- Markers of immune activation and viral load in HIV-associated sensory neuropathyNeurology, 2005
- HIV-Associated Distal Sensory Polyneuropathy in the Era of Highly Active Antiretroviral TherapyArchives of Neurology, 2004
- Neuropsychiatric impact of hepatitis C on advanced HIVNeurology, 2004
- Synergistic neurotoxicity of opioids and human immunodeficiency virus-1 Tat protein in striatal neurons in vitroNeuroscience, 2001
- Plasma viral load and CD4 lymphocytes predict HIV-associated dementia and sensory neuropathyNeurology, 1999
- Psychiatric Research Interview for Substance and Mental Disorders (PRISM): reliability for substance abusersAmerican Journal of Psychiatry, 1996
- Nucleoside analogue-associated peripheral neuropathy in human immunodeficiency virus infection.1995
- Reliability and validity studies of the WHO-Composite International Diagnostic Interview (CIDI): A critical reviewJournal of Psychiatric Research, 1994
- Enhancement of HIV-1 Replication by Opiates and Cocaine: The Cytokine ConnectionAdvances in experimental medicine and biology, 1993